Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight-threatening eye diseases, today announced that it has appointed Brian O’Callaghan to its Board of Directors.
“We are so pleased to welcome Brian to our Board. He brings to Acucela an impressive background and record of achievement in building biotechnology companies.
Help employers find you! Check out all the jobs and post your resume.
